Supernus Pharmaceuticals | Pasivo Circulante



Current Liabilities Cambio Fecha
Abbott USD 13.44B 435M 2025-06
ANI Pharmaceuticals USD 236.83M 35.02M 2025-06
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 144.66M 1.6M 2025-06
Eisai JPY 411.61B 39.31B 2025-06
Eli Lilly USD 39.02B 8.95B 2025-06
Novo Nordisk 207.52B 28.6B 2025-06
Pacira USD 313.16M 1.57M 2025-06
Perrigo USD 1.13B 52.3M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Supernus Pharmaceuticals USD 286.36M 4.59M 2025-06
United Therapeutics USD 527.1M 194.4M 2025-06
Xeris Pharmaceuticals USD 100.44M 9.43M 2024-12


Supernus Pharmaceuticals Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.